ESPN’s T.J. Quinn was a beat writer for many years, covering the White Sox and Mets and then moved on to do investigative reporting for the New York Daily News and ESPN, with a huge emphasis on covering performance enhancing drugs in sports. If there is any Hall of Fame voter, therefore, who is qualified to assess how PEDs and the Hall of Fame mix, it’s him.
Except he has decided that even he can’t do it and gave up voting for the Hall of Fame two years ago. Today he explains why:
Even before the issue of performance-enhancing drugs overwhelmed the annual conversation, I questioned my capacity to evaluate a player’s fitness for immortality. My only qualification, like all voters, was 10 years’ service as a BBWAA member. But nothing in my years as a beat writer covering the Chicago White Sox and New York Mets, and nothing in my years covering doping as an investigative reporter since has prepared me to evaluate the effect PED use should have on a player’s legacy.
He goes on to explain why the “keep the juicin’ bums out” arguments are essentially incoherent as generally applied. He also notes — as we have noted here at HBT lately — that it’s kind of a problem to give votes to guys who haven’t actively covered the game in years. Personally I think Quinn is eminently qualified, but even he himself thinks the fact that he hasn’t covered baseball on a day-to-day basis since 2002 prevents him from being up to the task. So who is?
But at the end of the day, the game, the Hall and journalism would be better served if voting was limited to a select group of veterans, historians and even journalists — if they’re the right journalists. Columnists and national writers who have devoted their careers to the game, not dabblers. That wouldn’t solve the problem of how to evaluate players in the age of modern chemistry, but at least the right group would be making the call.
I think it would be hard to come up with the right group of voters — ex-players are a particular problem as I think they are among the least suited to objectively analyze players’ contributions — but I think Quinn is right that the current electorate — ten-year BBWAA veterans who, quite often, aren’t even baseball writers anymore — is the wrong crop.
A lot of food for thought here. It’s nice to see someone with the franchise chewing on it all, even if he chooses not to vote.
Mets reliever Jenrry Mejia was permanently suspended on Friday after testing positive for a third time for a performance-enhancing drug. The right-hander is maintaining his innocence, as ESPN’s Adam Rubin notes in quoting Dominican sports journalist Hector Gomez. Mejia said, “It is not like they say. I am sure that I did not use anything.”
Mejia has the opportunity to petition commissioner Rob Manfred in one year for reinstatement to Major League Baseball. However, he must sit out at least two years before becoming eligible to pitch in the majors again, which would mean Mejia would be 28 years old.
Over parts of five seasons, Mejia has a career 3.68 ERA with 162 strikeouts and 76 walks over 183 1/3 innings. He was once a top prospect in the Mets’ minor league system and a top-100 overall prospect heading into the 2010 and ’11 seasons.
Nationals outfielder Bryce Harper is at least three years away from free agency, but people are already contemplating just how large a contract the phenom will be able to negotiate, especially after taking home the National League Most Valuable Player Award for his performance this past season.
When the likes of David Price and Zack Greinke are signing for over $200 million at the age of 30 or older, it stands to reason that Harper could draw more as a 26-year-old if he can maintain MVP-esque levels of production over the next several seasons. $400 million might not be enough for Harper, though, as MLB.com’s Jamal Collier reports. He said, “Don’t sell me short,” which is a fantastic response.
During the 2015 season, Harper led the majors with a .460 on-base percentage and a .649 slugging percentage while leading the National League with 42 home runs and 118 runs scored. He also knocked in 99 runs for good measure. Harper and Ted Williams are the only hitters in baseball history to put up an adjusted OPS of 195 or better (100 is average) at the age of 22 or younger.
Per Eric Stephen of SB Nation’s True Blue LA, the Dodgers announced that pitching prospect Frankie Montas will be out two to four months after undergoing rib resection surgery to remove his right first rib.
The Dodgers acquired Montas from the White Sox in a three-team trade in December 2015 that also involved the Reds. The 22-year-old made his big league debut with the Pale Hose last season, allowing eight runs on 14 hits and nine walks with 20 strikeouts in 15 innings across two starts. Montas had spent the majority of his season at Double-A Birmingham, where he posted a 2.97 ERA with 108 strikeouts and 48 walks in 112 innings.
MLB.com rated Montas as the 95th-best prospect in baseball, slipping a few spots from last year’s pre-season ranking of 91.
The Brewers’ rebuild continues, as the club announced on Twitter the trade of outfielder Khris Davis to the Athletics in exchange for catcher Jacob Nottingham and pitcher Bubba Derby. MLB.com’s Jane Lee reports that the A’s have designated pitcher Sean Nolin for assignment to create room on the 40-man roster for Davis.
Davis, 28, was the Brewers’ most valuable remaining trade chip. He blasted 27 home runs while hitting .247/.323/.505 in 440 plate appearances this past season in Milwaukee. Adding to his value, Davis won’t become eligible for arbitration until after the 2016 season and can’t become a free agent until after the 2019 season. In Oakland, Davis will give the Athletics more reliability as Coco Crisp was injured for most of last season and is now 36 years old. Though he doesn’t have much of a career platoon split, Davis split time in left field with the left-handed-hitting Gerardo Parra last season. It’s unclear if the A’s will utilize him in a platoon as well.
With Davis out of the picture, Domingo Santana is a leading candidate to start in left field for the Brewers, GM David Stearns said, per Tom Haudricourt of the Milwaukee Journal Sentinel.
Nottingham, 20, started the 2015 season in the Astros’ system but went to the Athletics in the Scott Kazmir deal. He hit an aggregate .316/.372/.505 at Single-A, showing plenty of promise early in his professional career. With catcher Jonathan Lucroy on his way out of Milwaukee, the Brewers are hoping Nottingham can be their next permanent backstop.
Derby, 21, made his professional debut last season after the Athletics drafted him in the sixth round. Across 37 1/3 innings, he yielded seven runs (five earned) on 24 hits and 10 walks with 47 strikeouts. He’s obviously a few years away from the majors, but the Brewers are looking for high upside.